Tuesday, November 10, 2009

A (Hypothetical) Letter to Consumers from Pharma

Dear Consumer:

I know I addressed this letter "Dear Consumer" but really I know you better than you think. You're a mom, a sister, a friend. A father, a husband, a son. You have a name. You might be someone that was just diagnosed, and you're seeking answers. You might be long-suffering from a chronic, debilitating disease, and you're seeking relief. Based on discussions with your doctor, you're hoping I can help you. What you may not know is, I'm really hoping I can help you, too.

My name is Pharma. And I'm not as bad as you think.

You might have been looking for information online recently. Let me guess ... Google, Yahoo, Bing? PatientsLikeMe.com? Online communities specific to your condition? You might even be searching and discussing on Facebook and Twitter. You're reading and connecting and looking for help, hope, and support wherever you can get it.

And I (Pharma) am noticeably absent.

I am sorry I can't talk to you. I really, really want to. But my hands are somewhat tied right now, my voice muffled. And I know you probably don't understand why. So here's my attempt at an explanation that I am hoping will help:

  • You probably already know that the FDA heavily regulates how pharmaceutical companies communicate with consumers if it can in any way be considered promotional or advertising in nature.
  • They do this for a reason - to help ensure your safety.
  • They want you to understand that there are risks associated with every drug. They want to make sure those risks are as up-front and obvious as all of the positive things we have to say about our drugs (hence all those side effects being mentioned in the TV ads you see).
  • FDA also wants to make sure that we (Pharma) talk about our drugs only in the context in which FDA approved them, or "on-label." For example, if a drug was approved by FDA to treat asthma but it is sometimes prescribed by a physician for COPD or another related illness, we just can't talk about that with you. That would be considered "off-label" promotion. Your doctor is the best person to discuss that with.
  • Also, FDA requires Pharma to report to FDA any drug side effects or "adverse events" from consumers. This is so that if there are any problems that arise with the drug, they want to be able to identify those problems early and address them quickly.
  • While the FDA has provided fairly clear guidelines on how pharmaceutical companies should address these three things -- balance of risks/benefits, on/off-label promotion, and side effect reporting -- when it comes to traditional advertising, the FDA has never told Pharma how they should use the Internet and social media to advertise. The only thing FDA has done is tell Pharma when it did something wrong.
So, it's not that the FDA says I cannot use the Internet or social media to communicate with you. They've just never been very clear on exactly HOW I can use these mediums without crossing the imaginary line. And by not providing clear guidance, it makes our lawyers and the other people responsible in our organizations very nervous. They don't know what the rules are, so they can't judge whether the communicators are following them or not. And if we break the rules, there can be pretty severe consequences in the forms of warning letters, steep fines, required corrective action, and other reprimands. So you can probably understand we don't like to risk it.

I know I've made mistakes in the past. I know you don't trust me. And I know staying silent certainly doesn't help.

In fact, I don't blame you for mistrusting me. I'm not communicative. I'm not transparent. I interrupt your 10:00 news with silly animated TV commercials featuring details of disgusting side effects. You search for information online but there's only so much I can say. You might even end up on my Web site and look for a place to ask a question, to submit a complaint, but there is none.

I hope things will change. I'm trying. With the upcoming FDA hearings, I am hoping not just to get direction on how to "advertise" to you on the Internet and within social media. I want to talk to you. Have a conversation. Get to know you. See what you need; see how I can help. To provide support ... when and where you need it. (And I'm interested to know ... do you even want to have a conversation with me?)

At the end of the day, I'm Pharma, but I'm a person too. I'm a mom, a sister, a friend. A father, a husband, a son.

Someday, perhaps, we'll be able to chat.


Sincerely,

Pharma

8 comments:

Lisa Emrich said...

Clever letter. I'm a patient, writer on HealthCentral, blogger, community leader of sorts...and these issues interest and affect me as well. I enjoyed the slides of your FDAsm presentation. Won't be there myself, but will come to the HealthCentral cocktail event. Just wanted to say that I understand and appreciate the message which folks on the other side of the fence are struggling with.

Jim said...

Hmm, I'm a little surprised this is the first comment. I guess it's because most Pharma marketers realize this post is exactly what Pharma should be saying to customers. Regardless of the silence, I offer one thing to think about:

Many of us have been talking a lot about how social media is a conversation. If it is truly a conversation and treated as such, it should never become promotional. No one really ever wants to have a promotional conversation. In my opinion, promotional conversations were a key contributor to Pharma's loss of the public's trust in the first place. That being said, maybe social media is Pharma's second chance to get customer conversations right.

Heather P. said...

Fantastic post, Wendy. Kudos to you.

Wendy W. Blackburn said...

Lisa - thank you so much for your post. It means a lot to hear from a patient leader in the community. I was concerned that the letter would come off as insincere, while my intent was quite the opposite. I really appreciate your perspective and that you can see the other side's viewpoint as well.

(It's really easy to hate pharma these days - thanks for taking the high road. :-) )

I am a tentative for the HealthCentral event - would love to talk more if I see you there!

Wendy W. Blackburn said...

Hi Jim: Thanks so much for your post. Sorry you were actually the second comment - I just wasn't fast enough on the trigger to publish them (you people stay up way too late reading blogs, BTW). Anyway - you make a fantastic point that while should social media be approached as a conversation, it should NEVER be a promotional conversation. I like the idea of social media being a big fat opportunity to "get it right." Hopefully we can all help our clients work successfully toward that end.

Wendy W. Blackburn said...

Heather - thanks for your post and for the support, it means a lot!

VaradhKrish said...

The letter is what Pharma has to say (in an uninterrupted way)about the intentions of Pharma within the regulatory limitations it had been subjected to and a starting point to make others think that Pharma not only can say this but also do so. Pharma can use this opportunity to demonstrate that conversations can be very helpful. Good one, Wendy.
regards
VaradhKrish

Greg said...

To add to Jim's thought, social media might not be our "second" chance . . . it might be our "last" chance to get it right.